IE33153L - Tertiary amino acids - Google Patents

Tertiary amino acids

Info

Publication number
IE33153L
IE33153L IE690397A IE39769A IE33153L IE 33153 L IE33153 L IE 33153L IE 690397 A IE690397 A IE 690397A IE 39769 A IE39769 A IE 39769A IE 33153 L IE33153 L IE 33153L
Authority
IE
Ireland
Prior art keywords
formula
group
compound
reacting
acid
Prior art date
Application number
IE690397A
Other versions
IE33153B1 (en
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IE33153L publication Critical patent/IE33153L/en
Publication of IE33153B1 publication Critical patent/IE33153B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms

Abstract

1,268,831. α(Cyclicaminophenyl) - aliphatic carboxylic acids. CIBA-GEIGY A.G. 26 March, 1969 [27 March, 1968; 3 Sept., 1968; 13 Jan., 1969], No. 15859/69. Heading C2C. Novel compounds of Formula I in which R 1 represents a hydrogen atom or a lower alkyl, cycloalkyl or cycloalkyl-lower alkyl group; Ph represents a phenylene radical or a phenylene radical substituted by one or more of the same or different substituents selected from lower alkyl, free hydroxy, free mercapto, lower alkoxy, lower alkylmercapto, halogeno, trifluoromethyl, nitro and amino groups; and A represents a lower alkylene or lower alkenylene radical that is unsubstituted or substituted by one or more of the same or different substituents selected from lower alkyl, hydroxy, mercapto, lower alkoxy, lower alkanoyloxy, lower alkylmercapto, halogeno and oxo groups; provided that R 1 represents a cycloalkyl or cycloalkyllower alkyl group, and/or A represents a lower alkenylene radical which may be substituted as defined above; and the functional acid and amino derivatives i.e. esters, amides, thioamides, morpholides, nitriles, hydroxamic acids, ammonium and metal salts, N-oxides, lower alkyl or phenyl lower alkyl, quaternary ammonium compounds and acid addition salts, ("lower" above and hereinafter denotes groups or compounds containing up to 7 carbon atoms) are prepared (a) by reacting a compound of Formula II in which A has the meaning given for Formula I and X 1 represents a grouping of the formula -CH(R 1 )-Y 1 , in which Y 1 represents an alkali metal atom, a halogeno-magnesium group or a reactive, esterified or etherified hydroxyl group, with a reactive derivative of carbonic acid or of formic acid, not more than one of the reactants containing a metal atom; or (b) oxidizing in a compound of the Formula II in which X 1 represents a grouping of the formula -CH(R 1 )-Y 2 , in which Y 2 represents a hydroxymethyl or borylmethyl group, a formyl group or a 1-lower alkenyl or lower alkenoyl group, the group represented by Y 2 ; or (c) reacting a compound of the Formula II in which X 1 represents a grouping of the formula -CH(R 1 )-Y 2 , in which Y 2 represents an ammonium group, with a metal cyanide; or (d) decarbonylating a compound of the Formula II in which X 1 represents a grouping of the formula -CH(R 1 )-Y 2 , in which Y 2 represents a carboxycarbonyl group; or (e) reacting a compound of the Formula II in which X 1 represents an acetyl group, with sulphur in the presence of ammonia or a primary or secondary amine; or (f) reacting a compound of the Formula II in which X 1 represents a halogeno-carbonyl group, with an R 1 -diazo compound and rearranging it by hydrolysis, alcoholysis, ammonolysis or aminolysis; or (g) reacting a compound of the Formula II in which X 1 represents a 1-lower alkenyl group, with carbon monoxide and water under acidic conditions; or (h) decarboxylating a compound of the Formula II in which X 1 represents a free or functionally converted grouping of the formula -C(R 0 )(R 1 )-C(=O)-OH, in which R 0 represents a carboxy group; or (j) converting in a compound of the Formula II, in which X 1 represents a free or functionally converted grouping of the formula or of the formula -C(=R 1 <SP>0</SP>)-C(=O)-OH, in which R‹ represents a free or reactive esterified hydroxyl group, and R 1 <SP>0</SP> represents a lower alkylidene or cycloalkylidene group, the group represented by R‹ into a hydrogen atom or the group represented by R 1 <SP>0</SP> into a group represented by R 1 , by reduction; or (k) reacting a compound of the Formula II in which X 1 represents a hydrogen atom or a metal atom or a metal grouping, with a reactive ester of a glycolic acid compound of the formula or a functional acid derivative thereof, in which Y 3 represents a reactive, esterified hydroxyl group; or (m) reacting a compound of the formula or a functional acid derivative thereof, in which X 2 represents a reactive esterified hydroxyl group, with a secondary amine of the formula AN-H or an alkali metal derivative thereof, or (n) reacting a compound of the Formula III in which X 2 represents a primary amino group, with a reactive esterified glycol of the formula HO-A-OH; and, if desired, converting an acid or amine group into the required derivative or a resulting derivative into the free acid and, if desired, reacting a compound of Formula I where R 1 is H with a metal and then a reactive ester of an alcohol R 1 OH, and if desired, followed by salt formation and/or resolution. α-Cyclopropyl-α-(4-piperidinophenyl) acetaldehyde is prepared by action of p-toluenesulphonic acid on 1-cyclopropyl-1-(4-piperidinophenyl)-ethylene oxide which is obtained from 4-piperidinophenyl cyclopropyl ketone by action of a reagent prepared from sodium hydride and trimethyl sulphonium iodide in dimethylsulphoxide. Pharmaceutical compositions having antiinflammatory activity and in conventional forms for enteral or parenteral administration comprise an above novel compound and a carrier therefor. [GB1268831A]
IE397/69A 1968-03-27 1969-03-25 Tertiary amino acids,process for their manufacture and compositions containing them IE33153B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71634768A 1968-03-27 1968-03-27
US75713668A 1968-09-03 1968-09-03
US79086369A 1969-01-13 1969-01-13

Publications (2)

Publication Number Publication Date
IE33153L true IE33153L (en) 1969-09-27
IE33153B1 IE33153B1 (en) 1974-04-03

Family

ID=27418953

Family Applications (1)

Application Number Title Priority Date Filing Date
IE397/69A IE33153B1 (en) 1968-03-27 1969-03-25 Tertiary amino acids,process for their manufacture and compositions containing them

Country Status (26)

Country Link
JP (1) JPS5330712B1 (en)
AR (7) AR193025A1 (en)
AT (8) AT291239B (en)
BE (1) BE730520A (en)
BG (3) BG20567A3 (en)
CH (11) CH563984A5 (en)
CS (8) CS153511B2 (en)
CY (1) CY809A (en)
DE (1) DE1913743A1 (en)
DK (1) DK145226C (en)
FI (1) FI52579C (en)
FR (1) FR2004827A1 (en)
GB (1) GB1268831A (en)
IE (1) IE33153B1 (en)
IL (1) IL31861A (en)
KE (1) KE2542A (en)
MY (1) MY7500152A (en)
NL (1) NL162647C (en)
NO (1) NO132199C (en)
OA (1) OA03609A (en)
PH (1) PH12640A (en)
PL (1) PL74820B1 (en)
RO (4) RO64901A (en)
SE (1) SE382812B (en)
SU (4) SU459886A3 (en)
YU (3) YU39926B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2025518A1 (en) * 1969-06-05 1970-12-10
DE2013376A1 (en) * 1970-03-20 1971-10-07 Merck Patent Gmbh Substituted phenylacetic acids and processes for their preparation

Also Published As

Publication number Publication date
IL31861A (en) 1974-03-14
CH563985A5 (en) 1975-07-15
SU428600A3 (en) 1974-05-15
CH563984A5 (en) 1975-07-15
SU419029A3 (en) 1974-03-05
CH563989A5 (en) 1975-07-15
CH566990A5 (en) 1975-09-30
CS153505B2 (en) 1974-02-25
BE730520A (en) 1969-09-26
NO132199C (en) 1975-10-08
YU149975A (en) 1982-06-30
CH566991A5 (en) 1975-09-30
BG20339A3 (en) 1975-11-05
RO66273A (en) 1981-08-17
SU421191A3 (en) 1974-03-25
AR193194A1 (en) 1973-04-11
PL74820B1 (en) 1974-12-31
DK145226C (en) 1983-03-28
YU39926B (en) 1985-06-30
IE33153B1 (en) 1974-04-03
IL31861A0 (en) 1969-05-28
CY809A (en) 1976-12-01
YU39532B (en) 1984-12-31
AT287685B (en) 1971-02-10
AR193024A1 (en) 1973-03-30
PH12640A (en) 1979-07-05
AT291239B (en) 1971-07-12
NL6903273A (en) 1969-09-30
CS153510B2 (en) 1974-02-25
YU200174A (en) 1982-06-30
NL162647C (en) 1980-06-16
FR2004827A1 (en) 1969-12-05
SE382812B (en) 1976-02-16
FI52579C (en) 1977-10-10
JPS5330712B1 (en) 1978-08-29
CH554859A (en) 1974-10-15
AT291234B (en) 1971-07-12
BG20340A3 (en) 1975-11-05
NL162647B (en) 1980-01-15
BG20567A3 (en) 1975-12-05
KE2542A (en) 1975-07-25
OA03609A (en) 1971-03-30
MY7500152A (en) 1975-12-31
CH563986A5 (en) 1975-07-15
CH563381A5 (en) 1975-06-30
RO64901A (en) 1979-08-15
CS153511B2 (en) 1974-02-25
CS153508B2 (en) 1974-02-25
RO61382A (en) 1976-10-15
AT291235B (en) 1971-07-12
AR194569A1 (en) 1973-07-31
RO66269A (en) 1979-03-15
CS153502B2 (en) 1974-02-25
CS153506B2 (en) 1974-02-25
AR192560A1 (en) 1973-02-28
CH559755A5 (en) 1975-03-14
FI52579B (en) 1977-06-30
YU39653B (en) 1985-03-20
AT291240B (en) 1971-07-12
DK145226B (en) 1982-10-11
CH563988A5 (en) 1975-07-15
CS153503B2 (en) 1974-02-25
DE1913743A1 (en) 1969-11-20
CS153504B2 (en) 1974-02-25
YU200074A (en) 1982-06-30
NO132199B (en) 1975-06-23
SU459886A3 (en) 1975-02-05
AR192864A1 (en) 1973-03-21
AR193025A1 (en) 1973-03-30
CH563983A5 (en) 1975-07-15
AR192699A1 (en) 1973-03-14
AT291237B (en) 1971-07-12
AT291241B (en) 1971-07-12
GB1268831A (en) 1972-03-29
AT291242B (en) 1971-07-12

Similar Documents

Publication Publication Date Title
GB1489241A (en) Use of organophosphonic acid esters and their hydrolysates as anticorrosive coatings and adhesion promoters
ES8801360A1 (en) Gasoline composition.
IE33153L (en) Tertiary amino acids
ES8201622A1 (en) Pigment-containing coating composition having a high solids content.
IE41877L (en) 12-azaprostaglandins.
KR850005453A (en) Method for preparing novel Δ4- and Δ5-androsten derivatives and pharmaceutical composition comprising the same
GB1495163A (en) Resolution of racemic pantolactone
IE44180L (en) Azaprostaglandins.
GB1479162A (en) Substituted thiadiazole-2-thiol compounds and the preparation thereof
IE822906L (en) Vinblastine derivatives
IE40676L (en) Dibenzo (thiepino or oxepino-) -pyrrole compounds
ES405385A1 (en) ((thenylidene amino)oxy)alkyl carboxylic acids and salts and esters thereof
IE37347L (en) Oxazoloazepines
GB1476384A (en) Liquid motor fuel compositions
GB1382606A (en) Benzoic acid derivatives
GB1488224A (en) 7alpha-methoxycephalosporin compounds
ES339557A1 (en) Process for lowering the hydroxyl group content of an epoxy resin by transesterification
ES430544A1 (en) Methoxy-cephalosporins and penicillins containing aminomethyl groups
GB1302015A (en)
ES432975A1 (en) Improvements introduced in a procedure to obtain a penama oxidated derivative. (Machine-translation by Google Translate, not legally binding)
ES439286A2 (en) N-substituted aminomethyl-methoxy penam and cephem compounds
ES469096A1 (en) Salts of DELTA &lt;3&gt;-cephem compounds with low water-solubility
KR860004043A (en) Method for preparing amino alkyl furan derivative
GB1420759A (en) Piperidine derivatives
GB1066017A (en) Process for rendering high molecular weight organic polymers resistant to electrostatic charge